An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

With the advent of the MDCT, the pancreas can be imaged at a very high spatial and temporal resolution and the study can be performed within a short breath hold. [7,8] Due to the near isotropic ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by distinct histological subtypes and a poor prognosis. Among these, the micropapillary pattern, typically observed ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

In the presence of invasive carcinoma, mucinous cystadenocarcinoma, the prognosis is similar to typical ductal adenocarcinoma of the pancreas which underscores the need to remove MCNs at the time of ...

Dr. Won Jin Ho presented a talk as part of the Immunology Neighborhood Seminar on “Overcoming the tumor immune ...

The Mayo research team found that the combination of cytology and FISH raised the detection rate of bile duct and pancreatic cancer from 20 percent to 43 percent. "Bile duct and pancreatic cancers ...

Basal cell carcinoma, for example, has a five-year survival rate of 100%. Pancreatic ductal adenocarcinoma, however, has a five-year survival rate of just 4%. Carcinoma is curable if detected early.